Member Info for RichKen

VanV, good to see you posting here. The long term potential with Avacta really looks multifaceted. A business which can grow through multiple revenue streams with mass requirements on each product, makes it look very strong as a future success story for investors.
As we await news to find out if the Affirmer technology will be totally successful as an accurate replacement for PCR testing with a fast reaction, low cost and easy and safe to carry anywhere, this product will revolutionise Covid19 testing.
The upside potential here is very exciting, true numbers can only be projected, up the reality is going to be very good either way.
Clearly the average AIM investor will say ‘its is worth a punt’ even at today’s price it has huge potential upside. The risk is there, but the experience of the Avacta team make it a strong calculated possible that we could be onto a long term winner here for Covid19 testing.
But, and the biggest positive and should be understood by everyone, is that this company can Transfor cancer treatments for patients around the world. Precise, targeted treatments will make every cancer sufferer much more comfortable and that is so important. For those who have never seen this for themselves they won’t understand in the same way. This pre-CISON technology is the future and it will be the long term future of this business.
Cheers RK

So we can run at up to 50% capacity!

This is great news! The plant will no doubt have had to maintain throughput in the kiln to ensure it can be ready to ramp up as required. Of course our mine at Vametco is open cast, so there are individual drivers in plant and the rest of the mine is highly mechanised so, it is quite reasonable to think that being able to keep safe social distancing to keep safe.
The output can then be controlled.
Clearly the plant has been able to continue shipping as we have seen from tracking of vessels (thanks Palindia) on the Bushveld Perspective.
The days ahead will reveal the due Q1 results which should be encouraging.
Q2 when the numbers come may we’ll be down by 50%, but if the next few weeks May and June result in higher vanadium prices the second quarter may prove to be as strong on revenue.
The market may have gone a little cold on Bushveld Minerals as the global market puts everyone in the same basket, but Bushveld Minerals have not gone cold on building a fantastic business and ensuring they can meet market needs.
We trust the whole workforce at Bushveld will be cared for in a positive way and there families will be well provided for knowing there loved ones will be safe and able to ensure they keep their families provided for in this most difficult of times.
This is good news for investors. Thanks Loudspeaker for sharing.
Cheers RK

Yes this is very clear. Antigen is to test if you have the virus and a antibody test is to see if you have either had the virus or potentially have immunity to the virus. Today’s headlines are that Antibody tests could be flawed.

Avacta are working and focusing on Antigen testing to replace PCR testing as a fast and reliable test which can be used anywhere safely without the need for any intrusion, any swabs, any labs or indeed anyone with medical training.

If proven and it becomes Deliverable it will be game changing.

This is the point.

Cheers RK

AVCT’s Point of care Antigen test, using the Affirmer technology applied to a dip stick saliva test which will offer the ability to test if you have the Covid19 virus in just minutes will truly change the need of the world to self isolate. The fact that Cytiva will be able to produce at scale around the world will make life possible again.
As a replacement for the PCR tests with potentially the accuracy to match it truly has the potential to change testing across the planet quickly.
The upside for Avacta is that the potential income from this single project could give it the traction to become a world leader in precision cancer treatments far more quickly, in terms of getting them to patients and oncology centres around the world would be two of the most important biotech projects to be completed.
That is what Avacta is currently all about. This is why for me this is such a great investment!
Anyone agree with this?
Cheers RK

You are certainly right AM! The speed which Bushveld can ramp up production will be highly advantageous as many others will be under pressure. The up coming demand is likely to increase much more than before as many infrastructure projects both in construction and energy storage get switched on.
Largo and Bushveld will have a much stronger control of the vanadium prices than before, which will be good for both. Bushveld clearly are ahead on the energy storage VRFB market, but we can be sure that Largo too will want a growing share of this market. With reduced stock of vanadium for the steel strengthening market, FeV prices and Nitrovan prices will rise.
What a Stella moment to look at investing in Bushveld Minerals. Last time we saw a rapid increase in the price of vanadium our share price rose very strongly. This time we have 50% more capacity and we have approval and a license to open the worlds largest high grade vanadium mine in the world.
This really could be our time. 2020 al ways had the potential to be significant. Once lockdowns are reduced this could be a very fast growing opportunity.
Exciting times could be ahead!
In the meantime I hope all are well and staying safe!
Cheers RK

The key factors which make BMN investable:

- Bushveld Minerals are a "Profitable Vertically Integrated Vanadium Business!"
- With 3 mines – Vametco, Brits and Mokopane
- Nitrovan is a key product to strengthen steel from its Vametco Mine
- Vanadium is also used in a breaking electrolyte technology used in large energy storage batteries
- Bushveld has two processing plants Vametco 3200 mtV and Vanchem 1100 mtV - currently producing a combination of 4300 mtV, in last year with an average selling price of circa US$40 per kilo with an operating cost of circa US$19 – but operation costs are now much lower in 2020
- Bushveld has plans to more than double the capacity of these two plants to 8400 mtV pa within 3 years
- Of the 3 mines Vametco is in full operation, Brits is an extension to Vametco and Mokopane which has its licence for mining fully approved and this will be the largest high-grade Vanadium mine in the world – DFS later this year and expect the mine to be opened in 2021
- Bushveld has built up a new division called Bushveld Energy which has part ownership of Invinity Energy Storage plc and Enerox GmbH part of its VIP program.
- Bushveld Energy has installed at the Eskom Battery Test facility a VRFB which has been operational over a year which is being used for evaluation purposes
- The Bushveld Electrolyte Company is building a Vanadium Electrolyte 200MWh plant in East London (SA)
- The Electrolyte plant will eventually have the capacity for 1000MWh of electrolyte
- 1000MWh of electrolyte needs approximately 5000 mtV per year
- Bushveld Energy is working with multiple partners around the world through Vanitec to build the strongest business case for VRFB
- Bushveld Energy plan to build an assembly plant for VRFB is SA – an Enerox subsidiary is possible?
- The world supply chain for vanadium remains in deficit and today even more so, Bushveld Minerals are so far ahead of the other players. Prices will be rising quickly.

Vanadium prices are rising in 2020 with the price today close to US$26 per kilo and our cost is well below US$15 per kilo and we will be producing just under 4,300,000 kilos of vanadium in 2020!

The current limited supply puts Bushveld in one of the strongest positions as a primary Vanadium supplier with strong revenue growth predicted year on year!

If you are not sure - then read this:

Last reported financial position is:
https://polaris.brighterir.com/public/bushveld_minerals/news/rns/story/xj0117w

Latest broker report following 2019 Q4 from SP Angel:
https://www.uploadlibrary.com/SPAngel_JohnMeyer/Bushveld_Q4_Operational_Production_Update_January_2020.pdf

Latest company presentation – February 2020:
http://www.bushveldminerals.com/wp-content/uploads/2020/02/BMN-Mining-Indaba-2020-Corporate-Presentation-Updated04022020.pdf

The Interview with our CEO's “two is better than one”:
https://youtu.be/p3QUjIL1rJQ

Cheers RK

11 Apr 2020 11:03
It is great to welcome new investors to Bushveld Minerals share chat!

This board has regular contributions from from many long term holders who have huge expertise and knowledge on the vanadium market and the opportunities which are growing.

We recommend of course researching as much as you can. Bushveld Minerals have an excellent website with presentations and market information. Many of the private investors also grouped together and through one of our key contributors here set up The Bushveld Perspective website. This website is in the form of a online magazine with much information, articles and videos and interviews which will enlighten any new investor.
The Vanadium market is grounded in supplying Ferro Vanadium and Vanadium Pentoxide (V205) into the steel market for many years. One kilo of vanadium added to 1000 kilos of steel doubles the strength - critical for rebar used in construction.
But, the new market which is growing very quickly is energy storage and vanadium is used in what is called a vanadium redox flow battery which offers key advantages over a lithium ion battery. The market is massive and Bushveld Minerals, not only has the three mines, but the largest high grade resource in the world but has low cost processing plants too. They are building a one megawatt hour vanadium electrolyte plant and they have partnerships with vanadium redox flow battery manufacturers.
The company is very profitable and will grow quickly. It is a very exciting prospect fo r investors after the rapid fall in SP since the outbreak of Covid19. But, the processing plants have to run in low throughput to maintain them so limited processing remains. This will help a very fast recovery once the mines and plants come out of lock down.
The future for this business is incredible and it is very well run under the directorship of Fortune Mojepelo and Mikhail Nikomarov.
This is a compelling investment in a truly vertically integrated business.
Please enjoy researching and keep safe.
Cheers RK

DegsyAlmomd,
You are very right with the real reason that Alastair Smith is trying to maximise awareness of not only the company but the ease of use this product will have which will help everyone who is venerable to Covid19. Today it is about making sure that people have the awareness that solutions are just around the corner from their research - I hope!
Many people will be very worried about going back to normal and the impact on their health. Especially those who are at risk.
For investors here it doesn't give us any more than we already know. But it gives us optimism that the solution is very likely to achieve. No CEO whats to over-promise and certainly not under-deliver, so he is bound to be cautious.

I think all investors should be aware that this investment is not a single product company. There is much more to this business than Covid19 testing. Cancer effects of 1/3 of the world population and the most common treatment is chemotherapy and I can tell you it is awful for those going through it. The feeling of nausea, extreme tiredness and the risk of picking up infection can be life-threatening. So any solution that has the impact to reduce this is big news. For me, that is the real story here and Alastair was quick to point this out today. Good on him!

Have a great weekend!
Cheers, RK

YellowF1, just to be clear on this business I an no ramped, or pumper, or any other such share chat name. I have invested hard earned money in this business and with the new structure it has very good potential to build into a serious energy storage business.
That is all I have to say on this matter.
Cheers RK

Three buys from me this morning, £5, £10K and £6K.

There is no doubt in my mind that news on the completion of product testing is very close. That will be why Alastair Smith will be doing all these interviews! This product is likely to be everywhere!

This one is going to be huge, in my opinion. Even better with the targeted Pre-CISON Cancer treatments which will revolutionise the Oncology industry.

This Biotech company is certainly not a one-product business.

Off to tune in to Talk Radio!

Cheers, RK

Good morning all,
It is more than possible to hit this number or very close in the next few days.
This company holds the keys to rapid global testing and it will be around for some time.
The investors from other testing companies will see this too. There is no intrusive or difficulty required with this test and rapid results will be key to our future success.
We want live back to normal and this low cost test holds the keys.
Have a great day all!
Cheers RK

The key for me going forward is that times and focus if very different from what was RedT on its own. Avalon, had a different route to market, and the focus going forward continues this route with standard units being made inChina at low cost, with a guaranteed source of vanadium and vanadium electrolyte which will be run out as an operational cost not part of the upfront capital cost. The key advantages to VRFB apart from the usual, safe and no risk of fire, no loss of depth of charge, 25 to 30 year life and recyclable electrolyte, is that these energy storage systems can cycle multiple times per day charging and discharging and this earns energy companies revenue very quickly. It can even pay for the system in less than 12 months. The fact that it then lasts 25 years should make the lithium ion system on stationary energy storage systems redundant within 3 to 5 years.
Renewables energy is the future and of every technology currently suitable the VRFB is in top spot.
This new business is so well supported and connected today, it will succeed.
This Markey is opening up and coming from the educational perspective as a Bushveld share holder it stands up as a solid player in Europe, the US and Asia.
I understand those who have lost money being very upset, but you can’t carry on just thinking this is the same box, different label. It is a very different company and that is why it is now a strong part of my portfolio.
Just to make my points clear. People should invest because they believe in the company and product, not to try to hope you may get back losses.
If people stay and constantly post negative vibes it puts off potential investors and you may as well give up.
This company has a great future and I will do everything here and outside to enable projects to be brought to there notice.
Cheers RK

AL69,
I have to say firstly welcome to the LSE share chat board! I have to say that is one of the best first posts I have read. Makes such a refreshing change from the usual bold statements or inexperienced basic questions. When I first found LSE I read many boards and I already had a portfolio, but I wanted to gauge the initial approach to the board in a way to be accepted. You have done well. Thoroughly deserve all those recommendations.
This is a very strange time and to see many companies in this sector having exceptional success is good for investors and good for people as a whole.
The testing situation is going to be critical for some time and various test forms will be rolled out further PCR and POC (point of care).
There is space for all.
If a fast accurate POC test makes the grade, this could take over as the number one route, but it it is not ready yet and until it is this PCR testing from Premier Design sits at the top of the tests.
I wish you every success in your investments and your time on this boards. People from every background from novice to expert. The one piece of advice is everyone has there own agenda and it is not easy to gauge unless you know someone. So make your own decisions and stick by them.
I wish you and everyone here a good evening. Steady day, didn’t work out quite as some wanted, but holding steady is better than a huge fall.
Cheers RK

I was considering, they must be very confident that they are about to bring this Affirmer test to market. I am sure our CEO didn’t do the interview for the benefit of investors. He did it to make sure the UK government advisors were aware that they are close to this as a solution. They need publicity to get the ear. Government advisers watch all the news channels all the time to pick up new developments.
This must be close to being ready. You would not want to turn the heat up if you were not about to go live.
Our man Alastair seemed very sure and confident through the interview. This is looking good to me.
The huge market for testing both PCR and POC are needed at every level. But, I was greatly encouraged that Alastair Smith implied the Affirmer Point of Care test would be so accurate it would actually replace the need for PCR testing. If that is true then the speed of testing and accuracy will be an incredible step forward.
Anyone else think the same?
A good day all round. The focus once compiled will be to get approvals pronto.
Now then this really will become the focus and future of testing. Low cost, reliable and quick.
What is not to like. Plus you have a business which can switch on manufacturers at the drop of a hat. Cytiva have plants everywhere.
What a moment to be invested here!
Have a great evening everyone.
Cheers
RK

Most likely that sell is an inter MM transfer. Could be wrong though. Why sell so many, when we are in our way to a much larger number.
Cheers RK

Great interview, shame always it was cut short.
But key points made very well.
Glad I made that addition buy this morning!
Hopefully a lot more interest from here on in!
Cheers RK I

On the BBC they are saying social distancing will be needed until a vaccine is in place.

Prof Ferguson added: "Without that, our estimates show we have relatively little leeway; if we relax measures too much then we'll see a resurgence of transmission.
"What we really need is the ability to put something in their place. If we want to open schools, let people get back to work, then we need to keep transmission down in another manner.
"And I should say, it's not going to be going back to normal. We will have to maintain some level of social distancing, a significant level of social distancing, probably indefinitely until we have a vaccine available."

The key though they still miss out, having a low cost easy and quick test for everyone.

So we look forward to the moment when Avacta have it cracked with the 100% accurate Affirer and the partnership with Cytiva can activate full production of the “Point of Care” testing sticks.

Then we have a perfect product to help the world for the next two years, as the vaccine is hopefully rolled out to the most vulnerable.

I see we are creeping up bit by bit. Think we will be in a very good place by the end of April.

Cheers RK

Another £7k added in this morning, I really cannot see this lower price being around for long!
Cheers RK

Great post AshTrey!
That gives some very sensible numbers to the numbers!
Recommended!
Cheers RK

Not sold a share this morning!

Why do this people not understand what growth means, doubling capacity, increased global market.
This means buy and hold!
Not panic sell. The world of have go investors is helpless!
Some may sell 10% after a steep rise and have some to buy back in, but not sell up.
The fool and his money is easily parted!
Cheers RK